Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-Bis[2-(3,5-dichloropyridyloxy)] benzene

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 91-97

  Ledda Columbano, Giovanna M ^a   Pibiri, Monica ^a   Loi, Roberto ^a   Perra, Andrea ^a   Shinozuka, Hisashi ^b   Columbano, Amedeo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; CYCLIN D1; CYCLIN DEPENDENT KINASE; MITOGENIC AGENT; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER REGENERATION; MITOGENESIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0033888467     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64709-8     Document Type: Article

References (53)

1. Role of growth factors and cytokines in hepatic regeneration
2. Transcriptional control of liver regeneration
3. Liver regeneration
4. Cyclin dependent kinase: Engines, clocks, and microprocessors
5. Cell cycle control in mammalian cells: Role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin dependent kinase inhibitors (CKIs)
6. Cyclins and cyclin dependent kinases: A biochemical view
7. Cancer cell cycles
8. Inhibitors of mammalian G1 cyclin-dependent kinases
9. Exit from GO and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA
10. p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
11. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
12. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation
13. Cell biology: Cell cycle inhibitors may help brake growth as cells develop
14. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases
15. p21-Containing cyclin kinases exist in both active and inactive states
16. New functional activities for the p21 family of CDK inhibitors
17. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver
18. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration
19. CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/Cip-1/SDI-1) protein
20. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
21. Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP
22. In vivo hepatocyte proliferation is inducible through a TNF, and IL-6-independent pathway
23. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kB and AP-1 or expression of tumor necrosis factor-α
24. Hepatocyte proliferation induced by a single dose of a peroxisome proliferator
25. Liver regeneration versus direct hyperplasia
26. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CIP2B gene
27. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene
28. Role of PPAR α in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
29. Regeneration of mammalian liver
30. Hepatic regeneration: Current concepts and clinical implications
31. Cell polyploidy: Its relation to tissue growth and function
32. Variations in regenerative growth of mouse liver following partial hepatectomy
33. 3H-thymidine incorporation in the regenerating mouse liver
34. C-myc, c-fos, and c-jun regulation in the regenerating livers of normal, and H-2K/c c-myc transgenic mice
35. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
36. Expression of cellular oncogene during liver regeneration
37. C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment
38. Differences in the steady-state levels of c-fos, c-jun and c myc-messenger RNA during mitogen-induced liver growth and compensatory regeneration
39. Expression of myc, fos and H-ras associated with chemically induced cell proliferation in the rat liver
40. Changes in expression of CCAT/enhancer binding protein a (C/EBPa) and C/EBPβ in rat liver after partial hepatectomy but not after treatment with cyproterone acetate
41. 17b-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic simulation of G1-arrested human breast cancer cells
42. Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5 and 6 and increases cyclin mRNA expression in rat uterus
43. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4
44. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution
45. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: Differential induction mechanism of cyclin D1 and D3
46. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene
47. Colony-stimulation factor 1 regulates novel cyclins during the G1 phase of the cell cycle
48. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo
49. Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration
50. Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine
51. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans
52. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver
53. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator WY 14,643